| ID: | 155 | |
|---|---|---|
| Name: | Compound 155 | |
| Description: | Original numeration in publication: 5e | |
| Labels: | Training_set, Phthalazines | |
| CAS: | ||
| InChi Code: | InChI=1S/C30H23N3O/c1-21-11-13-22(14-12-21)15-20-28(34)23-16-18-25(19-17-23)31-30-27-10-6-5-9-26(27)29(32-33-30)24-7-3-2-4-8-24/h2-20H,1H3,(H,31,33)/b20-15+ |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.19 |
Khedr, F.; Ibrahim, M.-K.; Eissa, I. H. a. A., H. S.; El-Adl, K. Phthalazine-based VEGFR-2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluations. Arch. Pharm. (Weinheim) 2021, 354, e2100201. https://doi.org/10.1002/ardp.202100201 |
| 6.44158 |
Eq1: VEGFR-2 inhibition (Data used to train model) |